Aspire Biopharma Holdings, Inc.
ASBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.
Other share classesASBPW
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Aspire Biopharma Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Aspire Biopharma Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Fell Donald G. | Director | 20,000 | Jun 10, 2025 | 0 |
| PowerUp Sponsor LLC | 10% Owner | 2,870,000 | Aug 22, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2025 (view filing)5:25 PM ET | Jun 4-5 | 6 days | Fell Donald G.Director | PPurchaseCommon Stock, par value $0.0001 | +20.0K | $0.39 | +$7.80K | New position20.0K after | Amended2 lots |
| Aug 22, 2023 (view filing) | Aug 18 | 4 days | PowerUp Sponsor LLC10% Owner | SSaleClass A Ordinary Shares, par value $0.0001 | −4.32M | – | – | −60.1%2.87M after |